(Q31811146)

4 July 2017

title

Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study (English)

1 reference

multicenter clinical trial

4 July 2017

main subject

0 references

1 reference

Vecchi M

1

1 reference

4 July 2017

Meucci G

2

1 reference

4 July 2017

Gionchetti P

3

1 reference

4 July 2017

Beltrami M

4

1 reference

4 July 2017

Di Maurizio P

5

1 reference

4 July 2017

Beretta L

6

1 reference

4 July 2017

Ganio E

7

1 reference

4 July 2017

Usai P

8

1 reference

4 July 2017

Campieri M

9

1 reference

4 July 2017

Fornaciari G

10

1 reference

4 July 2017

de Franchis R

11

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Alimentary Pharmacology & Therapeutics

4 July 2017

published in

1 reference

4 July 2017

volume

15

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

251-256

1 reference

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00913.X

10.1046/J.1365-2036.2001.00913.X

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference